Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8704 |
High Similarity |
NPD2801 |
Approved |
0.8491 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8476 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8303 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8225 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8204 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8125 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8098 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8046 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8035 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7937 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7937 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7929 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7921 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7882 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7865 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7853 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7811 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7809 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7751 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7736 |
Intermediate Similarity |
NPD943 |
Approved |
0.773 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7709 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7674 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7669 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7665 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7665 |
Intermediate Similarity |
NPD2532 |
Approved |
0.765 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD1607 |
Approved |
0.763 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7558 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7546 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6799 |
Approved |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7487 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7425 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7312 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7297 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7256 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7253 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7253 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD919 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7168 |
Intermediate Similarity |
NPD920 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD37 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7127 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7127 |
Intermediate Similarity |
NPD5711 |
Approved |
0.712 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.71 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7091 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7056 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7052 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7035 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD1653 |
Approved |
0.702 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD7698 |
Approved |
0.702 |
Intermediate Similarity |
NPD7697 |
Approved |
0.702 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6985 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6983 |
Remote Similarity |
NPD4288 |
Approved |
0.6975 |
Remote Similarity |
NPD1470 |
Approved |
0.6974 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6965 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6957 |
Remote Similarity |
NPD4665 |
Approved |
0.6951 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD7801 |
Approved |
0.6946 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6936 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7003 |
Approved |
0.6914 |
Remote Similarity |
NPD6273 |
Approved |
0.6909 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6909 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6897 |
Remote Similarity |
NPD7874 |
Approved |
0.6897 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD3972 |
Approved |
0.6893 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD9494 |
Approved |
0.6884 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD5405 |
Approved |
0.6882 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD5408 |
Approved |
0.6882 |
Remote Similarity |
NPD5404 |
Approved |
0.6882 |
Remote Similarity |
NPD5406 |
Approved |
0.6879 |
Remote Similarity |
NPD6190 |
Approved |
0.6871 |
Remote Similarity |
NPD2797 |
Approved |
0.6871 |
Remote Similarity |
NPD3266 |
Approved |
0.6871 |
Remote Similarity |
NPD1203 |
Approved |
0.6871 |
Remote Similarity |
NPD3267 |
Approved |
0.6853 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD1201 |
Approved |
0.6826 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6825 |
Remote Similarity |
NPD7240 |
Approved |
0.6824 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.681 |
Remote Similarity |
NPD6696 |
Suspended |
0.68 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD5353 |
Approved |
0.679 |
Remote Similarity |
NPD1608 |
Approved |
0.679 |
Remote Similarity |
NPD9717 |
Approved |
0.6786
|
Remote Similarity |
NPD6535 |
Approved |